1. Tantiwetrueangdet, Anchalee, Panvichian, Ravat, Sornmayura, Pattana, Leelaudomlipi, Surasak, Macoska, Jill A. 2021. PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues. In BMC cancer, 21, 295. doi:10.1186/s12885-021-07994-3. https://pubmed.ncbi.nlm.nih.gov/33743635/
2. Kim, Bongjun, Huang, Yuanjian, Ko, Kyung-Pil, Kim, Carla, Park, Jae-Il. 2024. PCLAF-DREAM drives alveolar cell plasticity for lung regeneration. In Nature communications, 15, 9169. doi:10.1038/s41467-024-53330-1. https://pubmed.ncbi.nlm.nih.gov/39448571/
3. Kolur, Vijayakrishna, Vastrad, Basavaraj, Vastrad, Chanabasayya, Kotturshetti, Shivakumar, Tengli, Anandkumar. 2021. Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis. In BMC cardiovascular disorders, 21, 329. doi:10.1186/s12872-021-02146-8. https://pubmed.ncbi.nlm.nih.gov/34218797/
4. Ma, FeiFei, Zhi, Cheng, Wang, Minling, Yao, Mingze, Ji, Tianxing. 2020. Dysregulated NF-κB signal promotes the hub gene PCLAF expression to facilitate nasopharyngeal carcinoma proliferation and metastasis. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 125, 109905. doi:10.1016/j.biopha.2020.109905. https://pubmed.ncbi.nlm.nih.gov/32070873/
5. Liu, Xiaowei, Cai, Yuanxia, Cheng, Cheng, Wu, Yeming, Wu, Zhixiang. 2022. PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis. In Cell death & disease, 13, 178. doi:10.1038/s41419-022-04635-w. https://pubmed.ncbi.nlm.nih.gov/35210406/
6. Xie, Wei, Zhang, Leiying, Shen, Junjing, Han, Wenling, Liu, Xiaoyan. 2024. Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis. In BMC cancer, 24, 551. doi:10.1186/s12885-024-12296-5. https://pubmed.ncbi.nlm.nih.gov/38693472/